StockNews.com Begins Coverage on ObsEva (NASDAQ:OBSV)

Equities research analysts at StockNews.com began coverage on shares of ObsEva (NASDAQ:OBSV) in a research report issued on Friday. The firm set a “hold” rating on the stock.

ObsEva Price Performance

The stock has a market capitalization of $7.94 million, a price-to-earnings ratio of -0.11 and a beta of 0.68. The stock has a 50 day moving average price of $0.01. ObsEva has a 12 month low of $0.08 and a 12 month high of $2.14.

About ObsEva

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.